dbACP: A Comprehensive Database of Anti-Cancer Peptides

9 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp03352 Hymenochirin-1B KLSPETKDNLKKVLKGAIKGAIVAKMV Zaire dwarf clawed frog Membrane disruption and cell lysis Cytotoxicity assay, Cell TiterGlo Luminescent Cell viability assay A549 Lung cancer LC50 : 2.5 ± 0.2 μM
dbacp03353 Hymenochirin-1B KLSPETKDNLKKVLKGAIKGAIVAKMV Zaire dwarf clawed frog Membrane disruption and cell lysis Cytotoxicity assay, Cell TiterGlo Luminescent Cell viability assay MDA-MB-231 Breast cancer LC50 : 9.0 ± 0.3 μM
dbacp03354 Hymenochirin-1B KLSPETKDNLKKVLKGAIKGAIVAKMV Zaire dwarf clawed frog Membrane disruption and cell lysis Cytotoxicity assay, Cell TiterGlo Luminescent Cell viability assay HT-29 Colon cancer LC50 : 9.7 ± 0.2 μM
dbacp03355 Hymenochirin-1B KLSPETKDNLKKVLKGAIKGAIVAKMV Zaire dwarf clawed frog Membrane disruption and cell lysis Cytotoxicity assay, Cell TiterGlo Luminescent Cell viability assay HepG2 Liver cancer LC50 : 22.5 ± 1.4 μM
dbacp03356 Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV-NH2 Zaire dwarf clawed frog Induce apoptosis and cell cycle arrest LDH release assay, MTT assay NCI-H1299 Lung cancer MIC : 0 - 50 μM
dbacp03357 Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV-NH3 Zaire dwarf clawed frog Induce apoptosis and cell cycle arrest LDH release assay, MTT assay A549 Lung cancer MIC : 0 - 50 μM
dbacp03358 Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV-NH4 Zaire dwarf clawed frog Induce apoptosis and cell cycle arrest LDH release assay, MTT assay H460 Lung cancer MIC : 0 - 50 μM
dbacp03359 Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV-NH5 Zaire dwarf clawed frog Induce apoptosis and cell cycle arrest LDH release assay, MTT assay HepG2 Human hepatocellular carcinoma MIC : 0 - 50 μM
dbacp03360 Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV-NH6 Zaire dwarf clawed frog Induce apoptosis and cell cycle arrest LDH release assay, MTT assay PLC Human hepatocellular carcinoma MIC : 0 - 50 μM